Author
Listed:
- Yousif Elnour Elsharif
- Bakri Yousif Mohamed Nour
- Khidir Osman Alfaki
- Samah Abdelrahim Elawad
- Ahmed Alsiddiq Ebraheem
- Nassir Abakar
- Elhadi Abdalla Ahmed
Abstract
Background: Sudan, as a developing country, suffers from most of the risk factors related to the transmission of the hepatitis E virus (HEV). Objective: This study aimed to determine the sero-frequency of HEV in cancer patients and healthcare workers and its associated risk factors. Methods: A descriptive cross-sectional design was followed, recruited populations were 120 cancer patients and 120 healthcare workers. Sociodemographic data and risk factors of the study subject were collected using a questionnaire and patient records. HEV-specific anti-HEV IgM and IgG antibodies screened by a competitive ELISA technique. A Chi-square test was determined for the association between HEV IgG sero-positivity andsubject information. Results: The percentage of cancer patients positive for anti-HEV IgG and IgM antibodies was 50% (60/120) and 6.7% (8/120) while for the healthcare workers group was 25.8% (31/120) and 4.2% (5/120) respectively. The most documented risk factors for HEV among cancer patients were consumption of raw meat 94.2% (113/120), contact with animals 88.3% (106/120), and history of blood transfusion 81.7% (98/120) while raw meat consumption was commonly found in 94.2% (113/120) of healthcare workers group. A significant association was observed between IgG sero-positive healthcare workers and consumption of raw meat (p-value = 0.005). Conclusion: The HEV sero-positivity was found at a high rate in both study groups, which requires further studies on its prevalence, epidemiology, and prevention.
Suggested Citation
Yousif Elnour Elsharif & Bakri Yousif Mohamed Nour & Khidir Osman Alfaki & Samah Abdelrahim Elawad & Ahmed Alsiddiq Ebraheem & Nassir Abakar & Elhadi Abdalla Ahmed, 2024.
"Sero-Detection of HEV in Cancer Patients and Healthcare Workers, Sudan,"
European Journal of Biomedical Research, European Open Science, vol. 3(2), pages 1-5, March.
Handle:
RePEc:epw:biomed:v:3:y:2024:i:2:id:2081
DOI: 10.24018/ejbiomed.2024.3.2.81
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:biomed:v:3:y:2024:i:2:id:2081. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support Team (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejbiomed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.